The Schools of Medicine at Yale and University of Pittsburgh are joining forces with Three Lakes Foundation to accelerate a cure for pulmonary…

CHICAGO, March 17, 2021 /PRNewswire/ --Three Lakes Foundation (TLF) has announced that it has selected Yale University School of Medicine and the University of Pittsburgh School of Medicine to join the Three Lakes Consortium for Pulmonary Fibrosis (TLC4PF). Together, they will focus on advancing disease understanding with the goal to accelerate new treatments and curing this devastating lung condition.

"The TLC4PF is a multiyear, multimillion dollar initiative," said Dana Ball, executive director of Three Lakes Foundation. "The Consortium provides a framework for cooperation and coordination among leading pulmonary researchers at medical institutions dedicated to improving care and health outcomes through the development and delivery of new medicines."

Pulmonary fibrosis (PF) occurs when lung tissue becomes damaged and scarred. Over time, the scarring destroys the lungs, making it harder for oxygen to enter the bloodstream and causes breathing to become difficult. While 40-50,000 people are diagnosed each year with PF, another 40,000 die annually.

The TLC4PF aims to change how the disease is diagnosed and treated. The Consortium comprises three strategic workgroups that are interdependent of each other and each addresses a different challenge in new therapy development:

At least 10 institutions globally will be collaborating with Three Lakes Foundationand the TLC4PF investigators from the Schools of Medicine at Yale and University of Pittsburgh when the Consortium becomes fully operational. Their participation will be critical to paving the path to discovery, translation and development of clinical trials to study next-generation therapies designed to stop and repair PF.

"The Consortium is an integral component of our innovative PF ecosystem," said Cheryl Nickerson-Nutter, Ph.D., executive vice president of research & development at TLF. "Three Lakes Foundation is bringing together many of the top investigators in pulmonary research supported by well-known medical research institutions to collaborate on making a cure for PF a reality. Together, we can bring new hope to patients and their families."

About Three Lakes Foundation Three Lakes Foundation (TLF) is a nonprofit dedicated to servingas a catalyst for uniting research, industries, and philanthropy in pulmonary fibrosis. We connect entrepreneurs, advocates and institutions to an innovation ecosystem that will transform our approach to improve time to diagnosis and accelerate new therapies. To learn more, visit threelakesfoundation.org.

FOR INFORMATION, CALL:Marita Gomez630-936-9105

SOURCE Three Lakes Foundation

Original post:

The Schools of Medicine at Yale and University of Pittsburgh are joining forces with Three Lakes Foundation to accelerate a cure for pulmonary...